Trials / Completed
CompletedNCT02604680
A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris
A Randomized, Controlled Evaluation of the Safety and Efficacy of Topical Treatments for Moderate-Severe Facial Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 509 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 12 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to compare the safety and efficacy of multiple formulations of BLI1100 to a control group and placebo in treating patients with moderate-severe acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLI1100-1 | BLI1100-1 Topical gel |
| DRUG | BLI1100-2 | BLI1100-2 Topical gel |
| DRUG | BLI1100-3 | BLI1100-3 Topical gel |
| DRUG | BLI1100-4 | BLI1100-4 Topical gel |
| DRUG | Placebo | Placebo - Topical gel |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2015-11-13
- Last updated
- 2017-07-28
Locations
50 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02604680. Inclusion in this directory is not an endorsement.